BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 29052513)

  • 1. A method to reduce ancestry related germline false positives in tumor only somatic variant calling.
    Halperin RF; Carpten JD; Manojlovic Z; Aldrich J; Keats J; Byron S; Liang WS; Russell M; Enriquez D; Claasen A; Cherni I; Awuah B; Oppong J; Wicha MS; Newman LA; Jaigge E; Kim S; Craig DW
    BMC Med Genomics; 2017 Oct; 10(1):61. PubMed ID: 29052513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
    PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging Spatial Variation in Tumor Purity for Improved Somatic Variant Calling of Archival Tumor Only Samples.
    Halperin RF; Liang WS; Kulkarni S; Tassone EE; Adkins J; Enriquez D; Tran NL; Hank NC; Newell J; Kodira C; Korn R; Berens ME; Kim S; Byron SA
    Front Oncol; 2019; 9():119. PubMed ID: 30949446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNVSniffer: an integrated caller for germline and somatic single-nucleotide and indel mutations.
    Liu Y; Loewer M; Aluru S; Schmidt B
    BMC Syst Biol; 2016 Aug; 10 Suppl 2(Suppl 2):47. PubMed ID: 27489955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
    Garofalo A; Sholl L; Reardon B; Taylor-Weiner A; Amin-Mansour A; Miao D; Liu D; Oliver N; MacConaill L; Ducar M; Rojas-Rudilla V; Giannakis M; Ghazani A; Gray S; Janne P; Garber J; Joffe S; Lindeman N; Wagle N; Garraway LA; Van Allen EM
    Genome Med; 2016 Jul; 8(1):79. PubMed ID: 27460824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
    Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
    Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurately identifying low-allelic fraction variants in single samples with next-generation sequencing: applications in tumor subclone resolution.
    Stead LF; Sutton KM; Taylor GR; Quirke P; Rabbitts P
    Hum Mutat; 2013 Oct; 34(10):1432-8. PubMed ID: 23766071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
    Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
    BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized genomic analyses for cancer mutation discovery and interpretation.
    Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
    Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs.
    Saunders CT; Wong WS; Swamy S; Becq J; Murray LJ; Cheetham RK
    Bioinformatics; 2012 Jul; 28(14):1811-7. PubMed ID: 22581179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OutLyzer: software for extracting low-allele-frequency tumor mutations from sequencing background noise in clinical practice.
    Muller E; Goardon N; Brault B; Rousselin A; Paimparay G; Legros A; Fouillet R; Bruet O; Tranchant A; Domin F; San C; Quesnelle C; Frebourg T; Ricou A; Krieger S; Vaur D; Castera L
    Oncotarget; 2016 Nov; 7(48):79485-79493. PubMed ID: 27825131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
    Schrader KA; Cheng DT; Joseph V; Prasad M; Walsh M; Zehir A; Ni A; Thomas T; Benayed R; Ashraf A; Lincoln A; Arcila M; Stadler Z; Solit D; Hyman DM; Zhang L; Klimstra D; Ladanyi M; Offit K; Berger M; Robson M
    JAMA Oncol; 2016 Jan; 2(1):104-11. PubMed ID: 26556299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNooPer: a machine learning-based method for somatic variant identification from low-pass next-generation sequencing.
    Spinella JF; Mehanna P; Vidal R; Saillour V; Cassart P; Richer C; Ouimet M; Healy J; Sinnett D
    BMC Genomics; 2016 Nov; 17(1):912. PubMed ID: 27842494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel machine learning approach (svmSomatic) to distinguish somatic and germline mutations using next-generation sequencing data.
    Mao YF; Yuan XG; Cun YP
    Zool Res; 2021 Mar; 42(2):246-249. PubMed ID: 33709636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of Population Frequency Cutoffs for Filtering Common Germline Polymorphisms from Tumor-Only Next-Generation Sequencing Data.
    McNulty SN; Parikh BA; Duncavage EJ; Heusel JW; Pfeifer JD
    J Mol Diagn; 2019 Sep; 21(5):903-912. PubMed ID: 31251990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting statistical interaction between somatic mutational events and germline variation from next-generation sequence data.
    Hu H; Huff CD
    Pac Symp Biocomput; 2014; ():51-62. PubMed ID: 24297533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constructing germline research cohorts from the discarded reads of clinical tumor sequences.
    Gusev A; Groha S; Taraszka K; Semenov YR; Zaitlen N
    Genome Med; 2021 Nov; 13(1):179. PubMed ID: 34749793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating somatic tumor mutation detection without matched normal samples.
    Teer JK; Zhang Y; Chen L; Welsh EA; Cress WD; Eschrich SA; Berglund AE
    Hum Genomics; 2017 Sep; 11(1):22. PubMed ID: 28870239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurity: accurate tumor purity and ploidy inference from tumor-normal WGS data by jointly modelling somatic copy number alterations and heterozygous germline single-nucleotide-variants.
    Luo Z; Fan X; Su Y; Huang YS
    Bioinformatics; 2018 Jun; 34(12):2004-2011. PubMed ID: 29385401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benchmarking variant callers in next-generation and third-generation sequencing analysis.
    Pei S; Liu T; Ren X; Li W; Chen C; Xie Z
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32698196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.